Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 25, 2011 Arundhati Parmar	St. Jude: New Aortic Replacement Valve Approved St. Jude gets good news.
The Motley Fool July 21, 2011 Arundhati Parmar	New Hypertension Treatment from St. Jude Medical? St. Jude management is keeping mum on renal denervation.
The Motley Fool June 24, 2011 Arundhati Parmar	Data on St. Jude Migraine Treatment "Impressive" An effective migraine treatment would be very valuable for St. Jude.
The Motley Fool June 27, 2011 Arundhati Parmar	St. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.? St. Jude won't comment on whether the company plans to do a second clinical trial or whether it is confident it will win approval from the FDA without it.
American Family Physician October 1, 2006 Freeman & Shulman	Kawasaki Disease: Summary of the American Heart Association Guidelines Kawasaki disease is an acute vasculitis of childhood that predominantly affects the coronary arteries. The etiology of Kawasaki disease remains unknown, although an infectious agent is strongly suspected based on clinical and epidemiologic features.
American Family Physician April 15, 2003	Coronary Artery Disease: Reducing Your Risk What is coronary artery disease?... What causes CAD?... What can I do to lower my risk of CAD?
The Motley Fool July 18, 2008 Brian Orelli	St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down.
The Motley Fool July 12, 2011 Arundhati Parmar	FDA Allows Expansion of St. Jude Study to Treat Severe Depression St. Jude moves forward with treatment for depression.
BusinessWeek March 22, 2004 Robert Barker	St. Jude: An Insider Sign To Investors? St. Jude, the patron saint of lost causes, rarely has needed to look out for his namesake, St. Jude Medical (STJ ). Since its birth in 1976, this maker of artificial heart valves, defibrillators, catheters, and sundry other cardiac devices has led a blessed life. It's in excellent health today. So why are insiders dumping the stock?
The Motley Fool July 20, 2005 Stephen D. Simpson	Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that.
The Motley Fool January 26, 2005 Stephen D. Simpson	St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains.
American Family Physician November 15, 2004 Mark H. Ebell	Prognosis for Patients Undergoing Coronary Angioplasty Several clinical decision rules have been developed and validated to estimate the likelihood of short-term, in-hospital complications such as death, myocardial infarction, and urgent coronary artery bypass graft surgery.
American Family Physician December 15, 2001 Julia Tucker De Sanctis	Percutaneous Interventions for Lower Extremity Peripheral Vascular Disease Peripheral vascular disease is a common condition with variable morbidity affecting mostly men and women older than 50 years. More than 70 percent of patients diagnosed with the disease remain stable or improve with conservative management...
American Family Physician April 1, 2001 Joan Bedinghaus	Coronary Artery Disease Prevention: What's Different for Women? Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk...
Fast Company Christina Farr	AHA, Alphabet Set Aside $75 Million To Cure Coronary Heart Disease The American Heart Association, Verily (the company formerly known as Google Life Sciences), and European pharmaceutical giant AstraZeneca are investing the funds over a five-year period.
Nurse Practitioner November 2011 Tracy Brazziel et al.	Stopping the Wave of PAD Early detection and diagnosis of atherosclerotic disease is imperative. Here, learn the risk factors, screening and diagnosis for this disease.
American Journal of Nursing May 2009 Kristen J. Overbaugh	Acute Coronary Syndrome Coronary artery disease, in which atherosclerotic plaque builds up inside the coronary arteries and restricts the flow of blood (and therefore the delivery of oxygen) to the heart, continues to be the number-one killer of Americans.
BusinessWeek June 7, 2004 Gene G. Marcial	St. Jude's Bruise Should Clear Up Fast St. Jude Medical (STJ ) tumbled 2%, to $73, after it revealed that the FDA had delayed for a month the approval of its new Epic CRT-defibrillator.
The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.
American Family Physician August 1, 2004 Wiviott & Braunwald	Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Part II. Coronary Revascularization, Hospital Discharge, and Post-Hospital Care In patients hospitalized with UA/NSTEMI, one of the most important decisions is the early strategy of care regarding coronary angiography and revascularization.
The Motley Fool April 19, 2007 Billy Fisher	A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter.
The Motley Fool October 19, 2007 Billy Fisher	Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed.
The Motley Fool April 19, 2006 Stephen D. Simpson	St. Jude Lives and Learns Though dynamics in the ICD market caught it by surprise, this is still a quality med-tech company. Investors, take note.
Nursing Management May 2010 Urbanowicz & Taylor	Hybrid OR: Is it in your future? Having the availability of a hybrid suite creates new opportunities to combine endovascular and open surgery into one operative episode.
American Family Physician October 15, 2003 Gavin et al.	Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels.
The Motley Fool April 11, 2008 Brian Orelli	St. Jude's Heartfelt Acquisition Medical-device maker St. Jude purchases tiny EP MedSystems.
Managed Care November 2007	Headlines On Deadline . . . Improving imaging test utilization is a hot topic among insurers and providers... Pairing Zagat's methodology with WellPoint is the idea for the upcoming launch of a new online survey tool... etc.
Pharmaceutical Executive January 1, 2009 Amit Agarwal	Overlooked Opportunities For pharma companies facing a difficult economic climate, pairing diagnostics with therapies offers a powerful incentive: Manufacturers can improve sales by helping physicians find the most appropriate therapeutic option.
The Motley Fool January 18, 2012 Dan Caplinger	Has St. Jude Medical Become the Perfect Stock? St. Jude took a big step toward perfection when it initiated a big dividend in early 2011.
The Motley Fool July 25, 2011 Jason Moser	Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker.
Popular Mechanics November 15, 2007 Logan Ward	Laser-Based Gadget Finds the Bends for Astronauts, Navy Seals A researcher hopes to build a laptop-size device to detect the onset of decompression sickness, or the bends, on submarines, the International Space Station and dive boats.
The Motley Fool July 25, 2011 Jordan DiPietro	Should You Retire With St. Jude? I can't decide for you whether or not this is the best stock for retirement, but it has passed all four tests, which is pretty impressive.
The Motley Fool January 25, 2006 Stephen D. Simpson	Is St. Jude Next to Be Wooed? Can St. Jude build upon the jump-start opportunity from Guidant's troubles, or will further market share growth prove to be increasingly hard to come by? Investors, take note.
The Motley Fool June 7, 2011 Arundhati Parmar	St. Jude Medical Introduces Two Cardiac Devices in India St. Jude heads to the Subcontinent.
The Motley Fool February 8, 2006 Tim Beyers	Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Dominion Resources... Goodrich Petroleum... iPass... ITT Educational Services... St. Jude Medical...
American Family Physician January 15, 2002 Lori J. Mosca	Optimal Management of Cholesterol Levels and the Prevention of Coronary Heart Disease in Women Elevated levels of low-density lipoprotein cholesterol and triglycerides and low levels of high-density lipoprotein cholesterol are significant risk factors for coronary heart disease. Abundant data show inadequate utilization of lipid-lowering therapy in women...
American Family Physician July 15, 2000 Valerie Palda	Editorials PRE-OPportunity Knocks: A Different Way to Think About the Preoperative Evaluation...
American Family Physician July 1, 2000 Charles E. Ray, Jr.	Interventional Radiology in Cancer Patients Procedures performed by an interventional radiology specialist are becoming increasingly important in the management of patients with cancer....
The Motley Fool July 19, 2006 Stephen D. Simpson	Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too.
The Motley Fool January 9, 2007 Billy Fisher	St. Jude's Juiced-Up Q4 The medical-device maker shows stronger vital signs. Investors, take note.
American Family Physician March 15, 2005 Lockman et al.	Treatment of Cholesterol Abnormalities The relationship between coronary heart disease and elevated cholesterol levels has been recognized for many years, but now studies show an improvement in patient-oriented outcomes in patients receiving drug therapy.
AskMen.com Stephane Leung	Heart Disease Prevention Myths With heart disease still the No. 1 killer across the U.S. and Canada, readers should be wary of some of the myths related to heart disease -- such as simply being male puts you at higher risk.
The Motley Fool October 12, 2004 Jeff Hwang	The Phantom Stock Split "Boost" If St. Jude Medical's stock went up, it's not because it's worth any more.
Managed Care April 2004 Martin Sipkoff	Plans Go Directly to Patients, Describing Treatment Options HMOs are developing programs that encourage patients to question their physicians about their treatment options. Doctors are wary.
The Motley Fool April 23, 2011	St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
Managed Care January 2005 Maureen Glabman	Health Plans Strain To Contain Rapidly Rising Cost of Imaging PET, CT, MRI -- these and other imaging technologies are valuable but costly. Aetna, Cigna, and a few other plans lead in clamping down on unnecessary use.
Managed Care July 2006 Michael Levin-Epstein	High-Tech Imaging Full of Kickback Dangers Health plans and their members could save billions of dollars a year if radiology costs could be contained. Some managed care companies begin to take a hard look at what's behind the explosion in costs for radiological services.
Bio-IT World January 13, 2003 Malorye Branca	The Power of Expression Clayton Naeve's annual budget tripled overnight. Naeve is director of what was formerly called The Biotechnology Center, at St. Jude Children's Research Hospital. The windfall came from an anonymous donor who pledged $5 million a year to the Center for the next five years.
Managed Care June 2005	Quick Results, Not Self-Referrals, Fuel Increase in Imaging Tests The researchers say that if self-referral were an important driver of the number of imaging services, they would have seen an acceleration in the growth of imaging services from 2001 to 2003 to offset the reductions in physician income brought about by reductions in the conversion factor.
American Family Physician July 1, 2005 Achar, Kundu & Norcross	Diagnosis of Acute Coronary Syndrome Differentiating acute coronary syndrome from noncardiac chest pain is the primary diagnostic challenge. The initial assessment requires a focused history (including risk factor analysis), a physical examination, an ECG and, frequently, serum cardiac marker determinations.